MA-NETCRACKER-TECHNOLOGY
3.6.2020 14:02:09 CEST | Business Wire | Press release
Netcracker Technology announced today the launch of its Netcracker 2020 portfolio to help service providers focus on their customer’s digital lifestyle. With Netcracker 2020 , service providers can transform customer engagement, dynamically evolve their digital ecosystems and reach new levels of automation and security, helping them to innovate and disrupt in the 5G digital economy.
Netcracker 2020 Digital BSS /OSS and Customer Engagement products and services have been redesigned and enhanced for the 5G era. The new digital portfolio is fully open and standards compliant, built for the cloud and allows service providers to develop their own enhancements or co-develop functions through a low code platform and blueprint delivery approach. With continuous short releases using Agile/DevOps processes, service providers gain faster access to innovative features with no disruptions to business operations. Central to Netcracker 2020 is an industry-leading security framework, designed to provide the highest level of proven system-wide security and privacy, which is critical in an era of increased cyber-attacks, intrusion and disruption.
In addition, as the world prepares for the uncertainty of a post COVID-19 environment, service providers want to increase the effectiveness of remote consumer and business interactions. With Netcracker 2020, they can radically transform customer engagement by anticipating their needs using AI-driven contextual interactions that go beyond problem solving and deliver relevant new services that combine service providers’ own services with those from partners and enriched with 5G experiences. As customers’ requirements become even more of a priority for service providers, personalized offerings can be dynamically created and delivered with a ground-breaking gaming-style user experience and cross-partner loyalty schemes.
Evolving to a more partner-based digital economy will require management of complex relationships, interconnections and business models with new and constantly changing partners, including other service providers. Netcracker 2020 helps build dynamic digital ecosystems that quickly adapt to changing business and market needs. With automated onboarding, simplified lifecycle management and partner-centric B2B2X opportunities, service providers will become both leaders and enablers of new platform-based monetization opportunities in diverse markets.
As services, networks and partnerships become more complex, full automation at every level has become a necessity. Netcracker 2020 uses a new operational model to remove manual tasks and drive hyper automation across network domains, services that cross domains, business processes and channels that are quickly moving towards open 5G networks with cloud-native functions and highly demanding edge cloud applications. Netcracker 2020 digital applications are cloud-native and designed to run in a multicloud environment, delivering the same high performance and resiliency on public clouds as on-premise cloud platforms. This also includes a security architecture and trust center that has become the industry benchmark.
“As BSS/OSS becomes increasingly critical to assure customer experience and enable security and flexible services, Netcracker has strengthened its position as the leader in helping service providers succeed in the highly competitive digital economy,” noted Sue Rudd, Director Networks and Service Platforms at Strategy Analytics. “Netcracker 2020 offers service providers a highly automated, multi-vendor microservices based environment to address their customers’ dynamic digital needs and sets the benchmark for modern BSS/OSS to accelerate revenue-generating service delivery in today’s uncertain world.”
“Netcracker 2020 is the culmination of over 25 years of experience of providing and operating mission-critical systems to hundreds of service providers around the globe in order to keep their businesses moving forward,” said Bob Titus, Chief Technology Officer, Netcracker. “This includes support for new business models, hyper automation, cloud adoption and the use of open source, outcome-based delivery models and, perhaps most importantly, an exceptional digital-first customer experience.”
About Netcracker Technology
Netcracker Technology, a wholly owned subsidiary of NEC Corporation, offers mission-critical digital transformation solutions to service providers around the globe. Our comprehensive portfolio of software solutions and professional services enables large-scale digital transformations, unlocking the opportunities of the cloud, virtualization and the changing mobile ecosystem. With an unbroken service delivery track record of more than 25 years, our unique combination of technology, people and expertise helps companies transform their networks and enable better experiences for their customers.
For more information, visit www.netcracker.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200603005135/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
